These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 34441382)
1. Late-Onset Medullary Thyroid Cancer in a Patient with a Germline Walczyk A; Zgubieński K; Chmielewski G; Hińcza-Nowak K; Kowalik A; Jaskulski J; Kowalska A Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441382 [No Abstract] [Full Text] [Related]
2. A Homozygous RET K666N Genotype With an MEN2A Phenotype. Jaber T; Hyde SM; Cote GJ; Grubbs EG; Giles WH; Stevens CA; Dadu R J Clin Endocrinol Metab; 2018 Apr; 103(4):1269-1272. PubMed ID: 29408964 [TBL] [Abstract][Full Text] [Related]
3. Elevated basal serum levels of calcitonin and simultaneous surgery of MEN2A-specific tumors. Tang HX; Yang H; Li F; Cao ZL; Huang YT; Qi XP Neoplasma; 2021 Sep; 68(5):1098-1106. PubMed ID: 34156257 [TBL] [Abstract][Full Text] [Related]
4. Long-term Clinicopathological Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by C634R Prabhu M; Shakya S; Ballal S; Shamim SA; Bal C Indian J Nucl Med; 2020; 35(1):48-53. PubMed ID: 31949369 [TBL] [Abstract][Full Text] [Related]
5. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma. Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251 [TBL] [Abstract][Full Text] [Related]
6. RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A. Chung YJ; Kim HH; Kim HJ; Min YK; Lee MS; Lee MK; Kim KW; Ki CS; Kim JW; Chung JH Thyroid; 2004 Oct; 14(10):813-8. PubMed ID: 15588376 [TBL] [Abstract][Full Text] [Related]
7. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B. Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899 [TBL] [Abstract][Full Text] [Related]
8. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation. Frank-Raue K; Raue F Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387 [TBL] [Abstract][Full Text] [Related]
9. RET germline mutation in codon 791 in a family representing 3 generations from age 5 to age 70 years: should thyroidectomy be performed? Brauer VF; Scholz GH; Neumann S; Lohmann T; Paschke R; Koch CA Endocr Pract; 2004; 10(1):5-9. PubMed ID: 15251615 [TBL] [Abstract][Full Text] [Related]
10. Medullary Thyroid Carcinoma Associated with Germline RET Xu JY; Grubbs EG; Waguespack SG; Jimenez C; Gagel RF; Sosa JA; Sellin RV; Dadu R; Hu MI; Trotter CS; Jackson M; Rich TA; Hyde SM; Sherman SI; Cote GJ Thyroid; 2016 Dec; 26(12):1744-1751. PubMed ID: 27673361 [TBL] [Abstract][Full Text] [Related]
11. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma. Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880 [TBL] [Abstract][Full Text] [Related]
12. [The clinical patterns and RET proto-oncogene identification of pheochromocytoma in 13 multiple endocrine neoplasia type 2A pedigrees]. Qi XP; Chen ZG; Jin HY; Li F; Cheng J; Ying RB; Zhao JQ; Guo DG; Luo SY; Chen GP; Zhang XN Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2200-4. PubMed ID: 24169328 [TBL] [Abstract][Full Text] [Related]
13. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees]. Zhou YL; Zhu SX; Li JJ; Liu JB; Yin M; Xiao BY; Yu CL; Wang LM; Gu LQ; Cui B; Ning G; Li XY; Zhao YJ Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the RET proto-oncogene and the phenotypic presentation of familial medullary thyroid carcinoma. Magalhães PK; de Castro M; Elias LL; Soares EG; Maciel LM Thyroid; 2004 Oct; 14(10):848-52. PubMed ID: 15588382 [TBL] [Abstract][Full Text] [Related]
15. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation. González-Yebra B; Medrano ME; Mantilla A; Palma V; Colin C; Hernández DM; Tapia J; Dawson B; Salcedo M Endocr Pathol; 2003; 14(1):71-80. PubMed ID: 12746565 [TBL] [Abstract][Full Text] [Related]
17. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia. Colombo-Benkmann M; Brämswig J; Höppner W; Gellner R; Hengst K; Böcker W; Senninger N World J Surg; 2002 Oct; 26(10):1286-90. PubMed ID: 12205548 [TBL] [Abstract][Full Text] [Related]
18. Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma. Raue F; Frank-Raue K J Endocr Soc; 2018 Aug; 2(8):933-943. PubMed ID: 30087948 [TBL] [Abstract][Full Text] [Related]
19. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A. Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030 [TBL] [Abstract][Full Text] [Related]